Lenvatinib Maintenance Therapy After Complete Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: Alternative Strategy in a Resource-limited Settingclinical and experimental pediatricsIF3.22025-03-010PRE
Portal Hypertension Due to TULP3-related Ciliopathy First Report From the Asia-Pacific Regionclinical and experimental pediatricsIF3.22024-11-010PRE
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first reportAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22024-06-016PRE
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant dataALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72023-12-185PRE
Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trialHEPATOLOGY INTERNATIONALIF6.12022-06-0711PRE
Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosisclinical and experimental pediatricsIF3.22022-05-0110OAAI
Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Studyclinical and experimental pediatricsIF3.22022-01-017OAAI
Cyproterone Acetate-Induced Acute Liver Failure: A Case Report and Review of the Literatureclinical and experimental pediatricsIF3.22021-11-011OAAI
Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure-A Pilot Studyclinical and experimental pediatricsIF3.22021-09-017OAAI
Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis新型冠状病毒肺炎对肝移植受者的影响-系统回顾和荟萃分析ECLINICALMEDICINEIF102021-08-0157OAAI
Early liver transplantation after COVID-19 infection: The first reportAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22021-06-0143OAAI
Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?HEPATOLOGYIF15.82021-05-176PREAI
Severe Acute Respiratory Syndrome Coronavirus 2-related Acute-on-chronic Liver Failureclinical and experimental pediatricsIF3.22021-05-0123OAAI
Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects (vol 10, 15232, 2020)SCIENTIFIC REPORTSIF3.92021-04-080OAAI
Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failureclinical and experimental pediatricsIF3.22021-03-016OAAI
Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19clinical and experimental pediatricsIF3.22021-03-015OAAI
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grailclinical and translational gastroenterologyIF4.22020-12-0945OAAI
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectivesLIVER INTERNATIONALIF5.22020-11-3045OAAI
Pathogenesis of Liver Injury in Coronavirus Disease 2019clinical and experimental pediatricsIF3.22020-11-0125OAAI